Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PTO Offers Faster Review Of Patent Applications, For A $4,000 Fee

Executive Summary

The U.S. Patent and Trademark Office is giving patent applicants the chance to get their applications processed within 12 months of submission for an additional fee of $4,000.

You may also be interested in...



Small Biotech Companies Could Get Faster USPTO Review Of COVID-19 Patent Applications

Pilot program aims to examine applications for COVID-19 products subject to approval by FDA within 6 to 12 months; the prioritized examination is available solely for small entities and would save them $2,000.

PTO To Streamline Patent Reexaminations Ahead Of Pending Legislation

Citing budget restraints, the Patent and Trademark Office is also postponing a program that would have given applicants the chance to get an application processed within 12 months.

Patent Office Would Get Ability To Set Fees Under House Bill; PTO To Allow Applicants To Fast Track One Application By Dropping Another

Since Congress is still tussling over a comprehensive patent reform bill, House Judiciary Committee Chairman John Conyers and Ranking Member Lamar Smith, R-Texas, introduced a stand-alone measure that would give the U.S. Patent and Trademark Office the authority to set its own fees for a 10-year period

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel